IDXX
IDEXX Laboratories·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Buy"
High Cash/net Profit Ratio
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About IDXX
Idexx Laboratories, Inc.
A global leading developer of diagnostic products and services for the veterinary market
Healthcare Equipment and Supplies
--
06/21/1991
NASDAQ Stock Exchange
11,000
12-31
Common stock
One IDEXX Drive, Westbrook, Maine 04092
Development and production of medical instruments and equipment
IDEXX Laboratories was incorporated in Delaware in 1983. The company mainly develops, manufactures and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. The company also provides human medical immediate care and laboratory diagnosis.
Company Financials
EPS
IDXX has released its 2025 Q4 earnings. EPS was reported at 2.92, versus the expected 2.93, missing expectations. The chart below visualizes how IDXX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
IDXX has released its 2025 Q4 earnings report, with revenue of 1.09B, reflecting a YoY change of 14.28%, and net profit of 248.19M, showing a YoY change of 14.82%. The Sankey diagram below clearly presents IDXX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
